Pure Global

Changying does not require the selection of the insulin-like growth factor II enzyme immune reagent - Taiwan Registration edc385fb836e6421d350e4b66a49ffa7

Access comprehensive regulatory information for Changying does not require the selection of the insulin-like growth factor II enzyme immune reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number edc385fb836e6421d350e4b66a49ffa7 and manufactured by DIAGNOSTIC SYSTEMS LABORATORIES, INC.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
edc385fb836e6421d350e4b66a49ffa7
Registration Details
Taiwan FDA Registration: edc385fb836e6421d350e4b66a49ffa7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Changying does not require the selection of the insulin-like growth factor II enzyme immune reagent
TW: ๅธธ็›ˆ ็„ก้œ€้ธ็ฒน่ƒฐๅณถ็ด ๆจฃ็”Ÿ้•ทๅ› ๅญII้…ต็ด ๅ…็–ซ่ฉฆๅŠ‘็ต„
Risk Class 2
Cancelled

Registration Details

edc385fb836e6421d350e4b66a49ffa7

DHA00601620705

Company Information

United States

Product Details

ๅฎš้‡ๆธฌๅฎšไบบ้ซ”่ก€ๆธ…ๆˆ–่ก€ๆผฟไธญ็š„IGF-II.

A Clinical chemistry and clinical toxicology

A.1370 Human Growth Hormone Testing System

import

Dates and Status

Mar 23, 2006

Mar 23, 2011

Nov 26, 2012

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ